API

 

ANTI HYPERTENSIVE
  SPECS EDMF(CTD) USDMF COS
Ramipril BP/EP/USP CEP 2006-040 19714 RO-CEP 2006-040-REV 01
Quinapril HCI USP 19413  
Benazepril HCI USP 20097  
Perindopril Tert-butylamine EP/BP    
Ranloazine Di-HCI / Base INHOUSE 21866  
Lacidipine EP/BP *  
ANTI ASTHAMATIC
Budesonide BP/EP/USP CEP 2006-295 20609 RO-CEP 2006-295-REV 00
Bambuterol HCI EP/BP    
R-Salbutamol Sulphate INHOUSE    
Levalbuterol HCI USP/INHOUSE 20557  
Levalbuterol Tartrate INHOUSE * *  
Salmeterol Xinafoate EP/BP CEP 2008-239 APPLIED
Ipratropium Bromide  INHOUSE CEP 2008-150 21179 APPLIED
Ciclesonide INHOUSE      
Fluticasone Propionate INHOUSE CEP 2007 -262 * APPLIED
Fluticasone Furoate INHOUSE      
Mometasone Furoate Monohydrate INHOUSE *  
ANTI CANCER
Gemcitabine HCI USP      
Bicalutamide USP JAN 09 INHOUSE 20502  
Ifosfamide BP/EP/USP * *  
Mesna EP/BP APPLIED
Mercaptopurine BP/EP/USP      
Irinotecan HCI Trihydrate INHOUSE      
Temozolomide INHOUSE      
Azathioprine BP/EP/USP      
CNS AGENT
Venlafaxine HCI EP CEP 2006-183 19879 RO-CEP 2006-183-REV 00
Quetiapine Fumarate INHOUSE 21336  
Oxcarbazepine INHOUSE      
Desvenlafaxine INHOUSE      
SKIN CARE
Mometasone Furoate  BP/EP/USP CEP 2007-302 21334 APPLIED
Desonide INHOUSE   *  
Triamcinolone acetonide BP/EP/USP      
Adapalene INHOUSE * *  
ANTI THALASSAEMIC
Deferiprone INHOUSE      
* Validation batches completed DMF under compilation

 

Note :

  1. Intermediates of above APIs will be available.
  2. Products Under Patent will not be sold until patent expiration in buyer's country.
  3. Purchase of any Patented Product will be sole responsibility of the Buyer.

Top